TipRanks - 2025-06-18 13:20
Northstrive Biosciences announced the initiation of Phase II of the AI Development Program with strategic partner Yuva Biosciences. As part of the Phase II objective, both companies will collaborate to leverage MitoNova, YuvaBio’s AI mitochondrial science-focused artificial intelligence platform, to compile a selection of small molecule candidates that promote mitochondrial health in obesity and cardiac diseases. YuvaBio will use MitoNova to virtually screen a large-scale library of diverse, dru